“…Phosphorylated FOXO1 induced by increased insulin levels is excluded from the nucleus, thereby decreasing its transcriptional activity [5,12,13]. In contrast, the decreased blood insulin levels during fasting promote FOXO1 nuclear localisation, where it collaborates with peroxisome proliferator-activated receptor, γ, co-activator 1 α (PGC-1α) to increase the expression of the key gluconeogenic genes, Pck1 and G6pc, via direct binding to insulin response elements (IREs) in their promoters [2,11,14,15]. Hepatic FOXO1 deficiency in mice impairs fasting-induced gluconeogenesis, subsequently leading to lowered blood glucose level [8].…”